You are here:Library»Library
Library
Monday, 06 September 2010 17:51
Written by DocConnect Team
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers.  Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) may have solved the problem by developing a new mathematical model that encompasses all dose levels. More
Monday, 06 September 2010 17:50
Written by DocConnect Team
CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive. Since 2003, the CyberKnife Center of Miami and the CyberKnife Center of Palm Beach have been providing this high tech cancer treatment longer than any facility in South Florida.  Prostate Cancer is diagnosed in more than a quarter of a million men each year in the U.S. Treatment options in existence which are non-invasive with little to no side effects are practically none. CyberKnife treatment for prostate cancer as discussed in this video by James G. Schwade, M.D. executive…
Monday, 06 September 2010 17:50
Written by DocConnect Team
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).  To identify these abnormalities, doctors would need to perform routine biopsies on apparently normal kidney transplants rather than waiting for problems to occur. "Even for some transplants that would be expected to have a very long graft survival, protocol biopsies performed in the first year may indicate the kidney is undergoing damaging inflammation, which is associated with increased risk…